Patrick Michael Reeves, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Coxiella burnetii | 6 | 2023 | 37 | 2.010 |
Why?
|
Q Fever | 6 | 2023 | 38 | 1.990 |
Why?
|
Bacterial Vaccines | 5 | 2022 | 401 | 1.210 |
Why?
|
Heterocyclic Compounds | 3 | 2019 | 246 | 0.830 |
Why?
|
Proto-Oncogene Proteins c-abl | 3 | 2010 | 140 | 0.640 |
Why?
|
Immunity, Cellular | 2 | 2020 | 1557 | 0.560 |
Why?
|
Receptors, CXCR4 | 2 | 2019 | 727 | 0.530 |
Why?
|
Receptors, Lysosphingolipid | 1 | 2015 | 121 | 0.490 |
Why?
|
Clathrin | 1 | 2015 | 257 | 0.470 |
Why?
|
Endocytosis | 2 | 2015 | 958 | 0.470 |
Why?
|
Drug Discovery | 2 | 2017 | 1044 | 0.420 |
Why?
|
Variola virus | 1 | 2010 | 11 | 0.370 |
Why?
|
Virion | 2 | 2010 | 421 | 0.360 |
Why?
|
Monkeypox virus | 1 | 2010 | 42 | 0.360 |
Why?
|
Virus Release | 1 | 2010 | 38 | 0.360 |
Why?
|
src-Family Kinases | 2 | 2010 | 535 | 0.350 |
Why?
|
Immunity, Innate | 3 | 2023 | 3047 | 0.350 |
Why?
|
Paclitaxel | 1 | 2017 | 1728 | 0.340 |
Why?
|
Vaccines | 1 | 2017 | 832 | 0.320 |
Why?
|
Epitopes, T-Lymphocyte | 3 | 2022 | 823 | 0.290 |
Why?
|
Flow Cytometry | 1 | 2017 | 5864 | 0.280 |
Why?
|
Ovarian Neoplasms | 3 | 2019 | 4876 | 0.260 |
Why?
|
Poxviridae | 1 | 2005 | 37 | 0.250 |
Why?
|
T-Lymphocytes | 3 | 2022 | 10171 | 0.240 |
Why?
|
GPI-Linked Proteins | 2 | 2018 | 468 | 0.240 |
Why?
|
HSP70 Heat-Shock Proteins | 2 | 2018 | 397 | 0.220 |
Why?
|
Antigens, Bacterial | 2 | 2019 | 1155 | 0.210 |
Why?
|
Benzylamines | 3 | 2019 | 247 | 0.210 |
Why?
|
Vaccinia virus | 3 | 2010 | 331 | 0.200 |
Why?
|
Mesothelioma | 2 | 2018 | 807 | 0.170 |
Why?
|
Piperazines | 2 | 2010 | 2511 | 0.160 |
Why?
|
Immunomodulation | 2 | 2024 | 545 | 0.160 |
Why?
|
HLA-DR Antigens | 1 | 2020 | 630 | 0.160 |
Why?
|
Cancer Vaccines | 2 | 2018 | 1046 | 0.160 |
Why?
|
Mice | 13 | 2024 | 81101 | 0.150 |
Why?
|
Pyrimidines | 3 | 2010 | 3006 | 0.150 |
Why?
|
Vaccinia | 2 | 2010 | 71 | 0.150 |
Why?
|
Mice, Inbred BALB C | 2 | 2020 | 6209 | 0.140 |
Why?
|
Antibodies, Bacterial | 2 | 2022 | 1468 | 0.140 |
Why?
|
Chemokine CXCL12 | 1 | 2019 | 454 | 0.140 |
Why?
|
Cell Growth Processes | 1 | 2017 | 384 | 0.140 |
Why?
|
Drug Synergism | 2 | 2018 | 1745 | 0.140 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 11709 | 0.140 |
Why?
|
Hydroxychloroquine | 1 | 2020 | 426 | 0.130 |
Why?
|
Arrestins | 1 | 2015 | 73 | 0.130 |
Why?
|
Actins | 3 | 2010 | 2049 | 0.120 |
Why?
|
Animals | 16 | 2024 | 167768 | 0.120 |
Why?
|
Mice, Transgenic | 3 | 2024 | 9518 | 0.110 |
Why?
|
Sequence Analysis, RNA | 2 | 2022 | 2001 | 0.110 |
Why?
|
Systems Biology | 1 | 2017 | 482 | 0.110 |
Why?
|
Sphingosine | 1 | 2015 | 308 | 0.110 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2024 | 1463 | 0.110 |
Why?
|
Protein Kinase Inhibitors | 2 | 2010 | 5629 | 0.110 |
Why?
|
Mice, Inbred C57BL | 6 | 2024 | 22003 | 0.110 |
Why?
|
Dihydropyridines | 1 | 2012 | 68 | 0.100 |
Why?
|
Benzamides | 2 | 2010 | 1368 | 0.100 |
Why?
|
Xenopus | 1 | 2014 | 717 | 0.100 |
Why?
|
Immunologic Memory | 1 | 2019 | 1353 | 0.100 |
Why?
|
Killer Cells, Natural | 1 | 2020 | 2201 | 0.090 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2012 | 301 | 0.090 |
Why?
|
Monocytes | 1 | 2020 | 2570 | 0.090 |
Why?
|
B-Lymphocytes | 1 | 2024 | 4738 | 0.090 |
Why?
|
Influenza Vaccines | 1 | 2017 | 759 | 0.090 |
Why?
|
Tumor Microenvironment | 2 | 2022 | 3840 | 0.090 |
Why?
|
Immune Tolerance | 1 | 2019 | 2297 | 0.090 |
Why?
|
Fluorescent Dyes | 1 | 2017 | 1897 | 0.080 |
Why?
|
HeLa Cells | 1 | 2015 | 3096 | 0.080 |
Why?
|
Antibodies | 1 | 2017 | 2420 | 0.080 |
Why?
|
beta Catenin | 1 | 2014 | 1043 | 0.080 |
Why?
|
Enzyme-Linked Immunospot Assay | 2 | 2019 | 123 | 0.080 |
Why?
|
3T3 Cells | 1 | 2010 | 1084 | 0.080 |
Why?
|
HEK293 Cells | 2 | 2015 | 4257 | 0.080 |
Why?
|
Guinea Pigs | 2 | 2022 | 1317 | 0.080 |
Why?
|
Neoplasm Proteins | 2 | 2019 | 3609 | 0.080 |
Why?
|
Multiprotein Complexes | 1 | 2014 | 1120 | 0.070 |
Why?
|
Kidney Transplantation | 1 | 2023 | 4217 | 0.070 |
Why?
|
Data Interpretation, Statistical | 1 | 2017 | 2690 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2017 | 10748 | 0.070 |
Why?
|
Cell Line, Tumor | 3 | 2019 | 16886 | 0.070 |
Why?
|
Single-Cell Analysis | 1 | 2017 | 2379 | 0.070 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2019 | 4353 | 0.070 |
Why?
|
Poxviridae Infections | 1 | 2005 | 12 | 0.060 |
Why?
|
Down-Regulation | 1 | 2012 | 2904 | 0.060 |
Why?
|
Embryonic Stem Cells | 1 | 2012 | 1262 | 0.060 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2023 | 5649 | 0.060 |
Why?
|
Humans | 17 | 2024 | 758406 | 0.060 |
Why?
|
Myocytes, Cardiac | 1 | 2012 | 1655 | 0.050 |
Why?
|
Genes, bcl-2 | 1 | 2023 | 119 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3076 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3196 | 0.050 |
Why?
|
Chimerism | 1 | 2023 | 155 | 0.050 |
Why?
|
Mice, Mutant Strains | 1 | 2005 | 1751 | 0.050 |
Why?
|
Gene Expression Profiling | 1 | 2017 | 9404 | 0.050 |
Why?
|
Female | 10 | 2024 | 390323 | 0.050 |
Why?
|
Interferon-gamma | 2 | 2019 | 3156 | 0.050 |
Why?
|
Primates | 1 | 2023 | 523 | 0.040 |
Why?
|
Dendritic Cells | 2 | 2014 | 2723 | 0.040 |
Why?
|
Convalescence | 1 | 2019 | 106 | 0.040 |
Why?
|
Peptides | 2 | 2022 | 4341 | 0.040 |
Why?
|
Cell Line | 2 | 2010 | 15591 | 0.040 |
Why?
|
Virus Replication | 1 | 2006 | 2430 | 0.040 |
Why?
|
Cell Movement | 1 | 2010 | 5201 | 0.040 |
Why?
|
Transplantation Tolerance | 1 | 2023 | 605 | 0.040 |
Why?
|
Histocompatibility Testing | 1 | 2019 | 717 | 0.040 |
Why?
|
Disease Models, Animal | 3 | 2024 | 18119 | 0.040 |
Why?
|
Genetic Vectors | 1 | 2006 | 3380 | 0.030 |
Why?
|
Interleukin-2 | 1 | 2023 | 1888 | 0.030 |
Why?
|
Cytokines | 2 | 2023 | 7338 | 0.030 |
Why?
|
Cricetulus | 1 | 2018 | 815 | 0.030 |
Why?
|
Signal Transduction | 1 | 2019 | 23342 | 0.030 |
Why?
|
CHO Cells | 1 | 2018 | 1389 | 0.030 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2019 | 1446 | 0.030 |
Why?
|
Adaptor Protein Complex mu Subunits | 1 | 2014 | 19 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2004 | 2416 | 0.030 |
Why?
|
Adaptor Protein Complex 2 | 1 | 2014 | 42 | 0.030 |
Why?
|
Immunization | 1 | 2019 | 1227 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2012 | 18940 | 0.030 |
Why?
|
Cricetinae | 1 | 2018 | 2426 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2023 | 3208 | 0.030 |
Why?
|
HLA Antigens | 1 | 2019 | 1368 | 0.030 |
Why?
|
Neoplasms | 1 | 2022 | 22032 | 0.030 |
Why?
|
Pyridines | 1 | 2005 | 2859 | 0.030 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2019 | 1355 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2023 | 4342 | 0.030 |
Why?
|
Escherichia coli | 1 | 2004 | 4215 | 0.020 |
Why?
|
Proteins | 1 | 2006 | 6026 | 0.020 |
Why?
|
Survival Rate | 1 | 2005 | 12721 | 0.020 |
Why?
|
Molecular Weight | 1 | 2012 | 2185 | 0.020 |
Why?
|
Epidermal Growth Factor | 1 | 2012 | 695 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2014 | 2895 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2014 | 13245 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2018 | 3733 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2022 | 4549 | 0.020 |
Why?
|
Heart | 1 | 2020 | 4382 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2012 | 3069 | 0.020 |
Why?
|
Gene Expression | 1 | 2019 | 7583 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2018 | 8530 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2014 | 2433 | 0.020 |
Why?
|
Actin-Related Protein 2 | 1 | 2004 | 40 | 0.010 |
Why?
|
Actin-Related Protein 3 | 1 | 2004 | 48 | 0.010 |
Why?
|
Chronic Disease | 1 | 2019 | 9267 | 0.010 |
Why?
|
Wiskott-Aldrich Syndrome Protein, Neuronal | 1 | 2004 | 86 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2014 | 6520 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2014 | 6821 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 10146 | 0.010 |
Why?
|
Protein Binding | 1 | 2014 | 9311 | 0.010 |
Why?
|
Algorithms | 1 | 2022 | 13961 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 2012 | 3705 | 0.010 |
Why?
|
Survival Analysis | 1 | 2014 | 10112 | 0.010 |
Why?
|
Viral Vaccines | 1 | 2006 | 596 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2019 | 7403 | 0.010 |
Why?
|
Escherichia coli Infections | 1 | 2004 | 523 | 0.010 |
Why?
|
Oncogene Proteins | 1 | 2004 | 719 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8611 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2006 | 1404 | 0.010 |
Why?
|
DNA, Viral | 1 | 2006 | 2194 | 0.010 |
Why?
|
Viral Proteins | 1 | 2006 | 1801 | 0.010 |
Why?
|
Point Mutation | 1 | 2004 | 1593 | 0.010 |
Why?
|
Cytoskeletal Proteins | 1 | 2004 | 1342 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2004 | 3593 | 0.010 |
Why?
|
Middle Aged | 2 | 2024 | 219568 | 0.010 |
Why?
|
Escherichia coli Proteins | 1 | 2004 | 1065 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2012 | 14354 | 0.010 |
Why?
|
Proteome | 1 | 2006 | 1855 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2012 | 11471 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2004 | 2825 | 0.010 |
Why?
|
Male | 2 | 2024 | 358747 | 0.010 |
Why?
|
Phosphorylation | 1 | 2004 | 8297 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2004 | 4406 | 0.010 |
Why?
|
Apoptosis | 1 | 2006 | 9468 | 0.010 |
Why?
|
Aged | 1 | 2019 | 168218 | 0.000 |
Why?
|